The role of dietary vitamin K in the management of oral vitamin K antagonists

Blood Reviews

Volumn 26, Issue 1, 2012, Pages 1-14

  Holmes, Michael V ^a,b   Hunt, Beverley J ^a,c   Shearer, Martin J ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Coumarin anticoagulant drugs; Dietary vitamin K intakes; International Normalised Ratio; Menaquinones (vitamin K 2); Oral vitamin K antagonists; Phylloquinone (vitamin K 1); Vitamin K epoxide reductase; Vitamin K status

Indexed keywords

1,3 INDANDIONE DERIVATIVE; 4 HYDROXYCOUMARIN; ACENOCOUMAROL; ANTICOAGULANT AGENT; ANTIVITAMIN K; COUMARIN; FARNOQUINONE; FLUINDIONE; MENADIONE; MENADIONE EPOXIDE; MENAQUINONE; MENATETRENONE; OSTEOCALCIN; PHENINDIONE; PHENPROCOUMON; PHYTOMENADIONE; PHYTOMENADIONE OXIDE; PLACEBO; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE); WARFARIN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; CARBOXYLATION; CHEMICAL ANALYSIS; CONCENTRATION RESPONSE; DIETARY INTAKE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG HALF LIFE; DRUG POTENTIATION; DRUG SENSITIVITY; DRUG STABILITY; ENZYME INHIBITION; ENZYME SYNTHESIS; FOOD COMPOSITION; HEART ATRIUM FIBRILLATION; HUMAN; MAINTENANCE THERAPY; MALABSORPTION; NONHUMAN; NUTRITIONAL DEFICIENCY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE DRUG DOSE; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ADMINISTRATION, ORAL; ANTICOAGULANTS; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; VITAMIN K;

EID: 83355169610     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2011.07.002     Document Type: Article

References (98)

1. Link K.P. The discovery of dicumarol and its sequels. Circulation 1959, 19:97-107.
2. Suttie J.W. Vitamin K in health and disease 2009, CRC Press (Taylor & Francis Group, Boca Raton. First ed.
3. Wadelius M., Chen L.Y., Lindh J.D., Eriksson N., Ghori M.J., Bumpstead S., et al. The largest prospective warfarin-treated cohort supports genetic forecasting. Blood 2009, 113:784-792.
4. Rettie A.E., Wienkers L.C., Gonzalez F.J., Trager W.F., Korzekwa K.R. Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9. Pharmacogenetics 1994, 4:39-42.
5. Kamali F., Wynne H. Pharmacogenetics of warfarin. Annu Rev Med 2010, 61:63-75.
6. Caldwell M.D., Awad T., Johnson J.A., Gage B.F., Falkowski M., Gardina P., et al. CYP4F2 genetic variant alters required warfarin dose. Blood 2008, 111:4106-4112.
7. McDonald M.G., Rieder M.J., Nakano M., Hsia C.K., Rettie A.E. CYP4F2 is a vitamin K1 oxidase: an explanation for altered warfarin dose in carriers of the V433M variant. Mol Pharmacol 2009, 75:1337-1346.
8. Shearer M.J., McBurney A., Barkhan P. Studies on the absorption and metabolism of phylloquinone (vitamin K1) in man. Vitam Horm 1974, 32:513-542.
9. Harrington D.J., Soper R., Edwards C., Savidge G.F., Hodges S.J., Shearer M.J. Determination of the urinary aglycone metabolites of vitamin K by HPLC with redox-mode electrochemical detection. J Lipid Res 2005, 46:1053-1060.
10. Nakagawa K., Hirota Y., Sawada N., Yuge N., Watanabe M., Uchino Y., et al. Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme. Nature 2010, 468:117-121.
11. World Health Organization International Agency for Research on Cancer IARC monographs on the evaluation of carcinogenic risks to humans. Some antiviral and antineoplastic drugs, and other pharmaceutical agents 2000, 76:417-486. IARC Press, Lyon.
12. Hanson H.H., Barker N.W., Mann F.D. Clinical experiences with 4-hydroxycoumarin anticoagulant no. 63 and the antagonistic effect of menadione and vitamin K. Circulation 1951, 4:844-863.
13. Shearer M.J., Newman P. Metabolism and cell biology of vitamin K. Thromb Haemost 2008, 100:530-547.
14. Furie B., Bouchard B.A., Furie B.C. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 1999, 93:1798-1808.
15. Wu S., Liu S., Davis C.H., Stafford D.W., Kulman J.D., Pedersen L.G. A hetero-dimer model for concerted action of vitamin K carboxylase and vitamin K reductase in vitamin K cycle. J Theor Biol 2011, 279:143-149.
16. Park B.K. Warfarin: metabolism and mode of action. Biochem Pharmacol 1988, 37:19-27.
17. Price R., Fenton S., Shearer M.J., Bolton-Smith C. Daily and seasonal variation in phylloquinone (vitamin K1) intake in Scotland. Proc Nutr Soc 1996, 55:244A.
18. Harrington D.J., Booth S.L., Card D.J., Shearer M.J. Excretion of the urinary 5C- and 7C-aglycone metabolites of vitamin K by young adults responds to changes in dietary phylloquinone and dihydrophylloquinone intakes. J Nutr 2007, 137:1763-1768.
19. Olson R.E., Chao J., Graham D., Bates M.W., Lewis J.H. Total body phylloquinone and its turnover in human subjects at two levels of vitamin K intake. Br J Nutr 2002, 87:543-553.
20. Shea M.K., Booth S.L., Gundberg C.M., Peterson J.W., Waddell C., Dawson-Hughes B., et al. Adulthood obesity is positively associated with adipose tissue concentrations of vitamin K and inversely associated with circulating indicators of vitamin K status in men and women. J Nutr 2010, 140:1029-1034.
21. Shearer M.J., Harrington D.J., Bolton-Smith C., Clark K.G.A., Savidge G.F. A very low, fixed dose of warfarin has a minimal effect on the gamma-carboxylation of the vitamin K dependent coagulation factors but perturbs vitamin K metabolism. J Thromb Haemost 1997, (Supplement:708). (Abstract).
22. McCann J.C., Ames B.N. Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging?. Am J Clin Nutr 2009, 90:889-907.
23. Shearer M.J., Bach A., Kohlmeier M. Chemistry, nutritional sources, tissue distribution and metabolism of vitamin K with special reference to bone health. J Nutr 1996, 126:1181S-1186S.
24. Schurgers L.J., Vermeer C. Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis 2000, 30:298-307.
25. Conly J.M., Stein K. Quantitative and qualitative measurements of K vitamins in human intestinal contents. Am J Gastroenterol 1992, 87:311-316.
26. Suttie J.W. The importance of menaquinones in human nutrition. Annu Rev Nutr 1995, 15:399-417.
27. Shearer M.J., Vitamin K. Metabolism and nutriture. Blood Rev 1992, 6:92-104.
28. Booth S.L., Al Rajabi A. Determinants of vitamin K status in humans. Vitam Horm 2008, 78:1-22.
29. Parrish D.B. Determination of vitamin K in foods: a review. Crit Rev Food Sci Nutr 1980, 13:337-352.
30. Shearer M.J., Bolton-Smith C. The UK food data-base for vitamin K and why we need it. Food Chem 2000, 68:213-218.
31. Booth S.L., Sadowski J.A., Weihrauch J.L., Ferland G. Vitamin K1 (Phylloquinone) content of foods: a provisional table. J Food Compos Anal 1993, 6:109-120.
32. Booth S.L., Sadowski J.A., Pennington J.A.T. Phylloquinone (Vitamin K1) content of foods in the U.S. food and drug administration's total diet study. J Agric Food Chem 1995, 43:1574-1579.
33. Bolton-Smith C., Price R.J., Fenton S.T., Harrington D.J., Shearer M.J. Compilation of a provisional UK database for the phylloquinone (vitamin K1) content of foods. Br J Nutr 2000, 83:389-399.
34. McCance, Widdowson's The Composition of foods 2002, Royal Society of Chemistry, United Kingdom. 6th Revised ed.
35. Agricultural Research Service USDA National Nutrient Database for standard reference. Release 17 vitamin K (phylloquinone) (μg) content of selected foods per common measure, sorted alphabetically 2004, US Department of Agriculture, Available at. http://www.nal.usda.gov/fnic/foodcomp/Data/SR17/wtrank/sr17a430.pdf.
36. Ferland G., Sadowski J.A. Vitamin K1 (phylloquinone) content of green vegetables: effects of plant maturation and geographical growth location. J Agric Food Chem 1992, 40:1874-1877.
37. Ferland G., Sadowski J.A. Vitamin K1 (phylloquinone) content of edible oils: effects of heating and light exposure. J Agric Food Chem 1992, 40:1869-1873.
38. Matschiner J.T., Amelotti J.M. Characterization of vitamin K from bovine liver. J Lipid Res 1968, 9:176-179.
39. Duello T.J., Matschiner J.T. Characterization of vitamin K from pig liver and dog liver. Arch Biochem Biophys 1971, 144:330-338.
40. Duello T.J., Matschiner J.T. Characterization of vitamin K from human liver. J Nutr 1972, 102:331-335.
41. Nelson M. Methods and validity of dietary assessment. Human nutrition and dietetics 1999, Churchill Livingstone, Edinburgh. 10th ed. J.S. Garrow, W.P.T. James, A. Ralph (Eds.).
42. Bingham S.A., Gill C., Welch A., Day K., Cassidy A., Khaw K.T., et al. Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. 24h recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr 1994, 72:619-643.
43. Schurgers L.J., Geleijnse J.M., Grobbee D.E., Pols H.A.P., Hofman A., Witteman J.C.M., et al. Nutritional intake of vitamins K1 (Phylloquinone) and K2 (Menaquinone) in The Netherlands. J Nutr Environ Med 1999, 9:115-122.
44. Geleijnse J.M., Vermeer C., Grobbee D.E., Schurgers L.J., Knapen M.H., van der Meer I.M., et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004, 134:3100-3105.
45. Nimptsch K., Rohrmann S., Linseisen J. Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Am J Clin Nutr 2008, 87:985-992.
46. Booth S.L., Sokoll L.J., O'Brien M.E., Tucker K., Dawson-Hughes B., Sadowski J.A. Assessment of dietary phylloquinone intake and vitamin K status in postmenopausal women. Eur J Clin Nutr 1995, 49:832-841.
47. Booth S.L., Suttie J.W. Dietary intake and adequacy of vitamin K. J Nutr 1998, 128:785-788.
48. Thane C.W., Paul A.A., Bates C.J., Bolton-Smith C., Prentice A., Shearer M.J. Intake and sources of phylloquinone (vitamin K1): variation with socio-demographic and lifestyle factors in a national sample of British elderly people. Br J Nutr 2002, 87:605-613.
49. Thane C.W., Bolton-Smith C., Coward W.A. Comparative dietary intake and sources of phylloquinone (vitamin K1) among British adults in 1986-7 and 2000-1. Br J Nutr 2006, 96:1105-1115.
50. Cushman M., Booth S.L., Possidente C.J., Davidson K.W., Sadowski J.A., Bovill E.G. The association of vitamin K status with warfarin sensitivity at the onset of treatment. Br J Haematol 2001, 112:572-577.
51. Khan T., Wynne H., Wood P., Torrance A., Hankey C., Avery P., et al. Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin. Br J Haematol 2004, 124:348-354.
52. Sobczyńska-Malefora A., Harrington D.J., Lomer M.C., Pettitt C., Hamilton S., Rangarajan S., et al. Erythrocyte folate and 5-methyltetrahydrofolate levels decline during 6months of oral anticoagulation with warfarin. Blood Coagul Fibrinolysis 2009, 20:297-302.
53. Food and Nutrition Board, Institute of Medicine Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, manganese, molybdenum, nickel, silicon, vanadium and zinc 2001, National Academy Press, Washington, DC.
54. Johnson M.A. Influence of vitamin K on anticoagulant therapy depends on vitamin K status and the source and chemical forms of vitamin K. Nutr Rev 2005, 63:91-97.
55. Spratto G.R., Woods A.L. PDR nurse's drug handbook 2002, Thomson PDR, Revised ed.
56. Wells P.S., Holbrook A.M., Crowther N.R., Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med 1994, 121:676-683.
57. Harris J.E. Interaction of dietary factors with oral anticoagulants: review and applications. J Am Diet Assoc 1995, 95:580-584.
58. Lubetsky A., Dekel-Stern E., Chetrit A., Lubin F., Halkin H. Vitamin K intake and sensitivity to warfarin in patients consuming regular diets. Thromb Haemost 1999, 81:396-399.
59. Food and Nutrition Board Recommended dietary allowances (dietary reference intakes) 1989, National Academies Press, Washington, DC. 10th Revised ed.
60. Suttie J.W. Vitamin K and human nutrition. J Am Diet Assoc 1992, 92:585-590.
61. Lee W., Chung H.J., Kim S., Jang S., Park C.J., Chi H.S., et al. PIVKA-II is a candidate marker for monitoring the effects of the oral anticoagulant warfarin. Clin Biochem 2010, 43:1177-1179.
62. Schurgers L.J., Shearer M.J., Hamulyák K., Stöcklin E., Vermeer C. Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects. Blood 2004, 104:2682-2689.
63. Franco V., Polanczyk C.A., Clausell N., Rohde L.E. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. Am J Med 2004, 116:651-656.
64. Sconce E., Khan T., Mason J., Noble F., Wynne H., Kamali F. Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation. Thromb Haemost 2005, 93:872-875.
65. Rombouts E.K., Rosendaal F.R., van der Meer F.J. Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy. Br J Haematol 2010, 149:598-605.
66. Presse N., Kergoat M.J., Ferland G. High usual dietary vitamin K intake is associated with low relative variability in vitamin K intake: implications for anticoagulant therapy. Br J Haematol 2011, 153:129-130.
67. Kim K.H., Choi W.S., Lee J.H., Lee H., Yang D.H., Chae S.C. Relationship between dietary vitamin K intake and the stability of anticoagulation effect in patients taking long-term warfarin. Thromb Haemost 2010, 104:755-759.
68. Usui Y., Tanimura H., Nishimura N., Kobayashi N., Okanoue T., Ozawa K. Vitamin K concentrations in the plasma and liver of surgical patients. Am J Clin Nutr 1990, 51:846-852.
69. Caldwell P.T., Ren P., Bell R.G. Warfarin and metabolism of vitamin K1. Biochem Pharmacol 1974, 23:3353-3362.
70. Shearer M.J., McBurney A., Barkhan P. Effect of warfarin anticoagulation on vitamin-K 1 metabolism in man. Br J Haematol 1973, 24:471-479.
71. Shearer M.J., McBurney A., Breckenridge A.M., Barkhan P. Effect of warfarin on the metabolism of phylloquinone (vitamin K1):dose-response relationships in man. Clin Sci Mol Med 1977, 52:621-630.
72. Choonara I.A., Scott A.K., Haynes B.P., Cholerton S., Breckenridge A.M., Park B.K. Vitamin K1 metabolism in relation to pharmacodynamic response in anticoagulated patients. Br J Clin Pharmacol 1985, 20:643-648.
73. Park B.K., Choonara I.A., Haynes B.P., Breckenridge A.M., Malia R.G., Preston F.E. Abnormal vitamin K metabolism in the presence of normal clotting factor activity in factory workers exposed to 4-hydroxycoumarins. Br J Clin Pharmacol 1986, 21:289-293.
74. Kamali F., Edwards C., Butler T.J., Wynne H.A. The influence of (R)- and (S)-warfarin, vitamin K and vitamin K epoxide upon warfarin anticoagulation. Thromb Haemost 2000, 84:39-42.
75. Kurnik D., Lubetsky A., Loebstein R., Almog S., Halkin H. Multivitamin supplements may affect warfarin anticoagulation in susceptible patients. Ann Pharmacother 2003, 37:1603-1606.
76. Kurnik D., Loebstein R., Rabinovitz H., Austerweil N., Halkin H., Almog S. Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients. A prospective, controlled trial. Thromb Haemost 2004, 92:1018-1024.
77. Owren P.A. Thrombotest. A new method for controlling anticoagulant therapy. Lancet 1959, 2:754-758.
78. Owren P.A. The interrelationship between Normotest and Thrombotest. Farmakoterapi 1969, 25:1-13.
79. Multicentre evaluation of Normotest performance characteristics. Interlab variation, comparison of manual and instrumental techniques, reproducibility, normal range. Italian CISMEL study group. Scand J Haematol 1984, 32:501-506.
80. Arnesen H., Smith P. The predictability of bleeding by prothrombin times sensitive or insensitive to PIVKA during intensive oral anticoagulation. Thromb Res 1991, 61:311-314.
81. Karlson B., Leijd B., Hellstrom K. On the influence of vitamin K-rich vegetables and wine on the effectiveness of warfarin treatment. Acta Med Scand 1986, 220:347-350.
82. Pedersen F.M., Hamberg O., Hess K., Ovesen L. The effect of dietary vitamin K on warfarin-induced anticoagulation. J Intern Med 1991, 229:517-520.
83. Gijsbers B.L., Jie K.S., Vermeer C. Effect of food composition on vitamin K absorption in human volunteers. Br J Nutr 1996, 76:223-229.
84. Garber A.K., Binkley N.C., Krueger D.C., Suttie J.W. Comparison of phylloquinone bioavailability from food sources or a supplement in human subjects. J Nutr 1999, 129:1201-1203.
85. Schurgers L.J., Teunissen K.J., Hamulyák K., Knapen M.H., Vik H., Vermeer C. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 2007, 109:3279-3283.
86. Vermeer C., Shearer M.J., Zittermann A., Bolton-Smith C., Szulc P., Hodges S., et al. Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health. Eur J Nutr 2004, 43:325-335.
87. Kudo T. Warfarin antagonism of natto and increase in serum vitamin K by intake of natto. Artery 1990, 17:189-201.
88. Sconce E., Avery P., Wynne H., Kamali F. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood 2007, 109:2419-2423.
89. Rombouts E.K., Rosendaal F.R., Van Der Meer F.J. Daily vitamin K supplementation improves anticoagulant stability. J Thromb Haemost 2007, 5:2043-2048.
90. Bonjour J.P., Gueguen L., Palacios C., Shearer M.J., Weaver C.M. Minerals and vitamins in bone health: the potential value of dietary enhancement. Br J Nutr 2009, 101:1581-1596.
91. Schurgers L.J., Cranenburg E.C., Vermeer C. Matrix Gla-protein: the calcification inhibitor in need of vitamin K. Thromb Haemost 2008, 100:593-603.
92. Cockayne S., Adamson J., Lanham-New S., Shearer M.J., Gilbody S., Torgerson D.J. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2006, 166:1256-1261.
93. Conway S.P. Vitamin K in cystic fibrosis. J R Soc Med 2004, 97(Suppl 44):48-51.
94. EFSA panel on dietetic products Nutrition and Allergies (NDA). Scientific opinion on the substantiation of health claims related to vitamin K and maintenance of bone (ID 123, 127, 128 and 2879), blood coagulation (ID 124 and 126) and function of the heart and blood vessels (ID 124, 125 and 2880) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 on request from the European Commission 2009, 7:1228. EFSA, Available online. http://www.efsa.europa.eu.
95. de Assis M.C., Rabelo E.R., Avila C.W., Polanczyk C.A., Rohde L.E. Improved oral anticoagulation after a dietary vitamin k-guided strategy: a randomized controlled trial. Circulation 2009, 120:1115-1122. 3 p following 22.
96. Hylek E.M., Heiman H., Skates S.J., Sheehan M.A., Singer D.E. Acetaminophen and other risk factors for excessive warfarin anticoagulation. Jama 1998, 279:657-662.
97. Jones K.S., Bluck L.J., Wang L.Y., Stephen A.M., Prynne C.J., Coward W.A. The effect of different meals on the absorption of stable isotope-labelled phylloquinone. Br J Nutr 2009, 102:1195-1202.
98. Custodio das Dores S.M., Booth S.L., Martini L.A., de Carvalho Gouvea V.H., Padovani C.R., de Abreu Maffei F.H., et al. Relationship between diet and anticoagulant response to warfarin: a factor analysis. Eur J Nutr 2007, 46:147-154.